港A芯片股集體走低,北方華創、北京君正跌超5%,“芯片法案”今晚簽署
格隆匯8月9日丨此前持續多日活躍的芯片股今日集體走低,其中,A股北京君正、北方華創、華峯測控跌超5%,復旦微電、芯源微、瑞芯微、安集科技跌超4%;港股華虹半導體跌4%,中芯國際跌超1%。拜登將於北京時間今日22:00簽署芯片法案,該法案為美國半導體產業提供補貼、使美國在與中國的競爭中更具競爭力。法案包括為芯片製造和研究提供520億美元的補貼,和價值240億美元的投資税收抵免,鼓勵企業在美國研發和製造芯片。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.